Temasek Holdings’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-279,693
| Closed | -$3.26M | – | 147 |
|
|
2024
Q4 | $3.26M | Hold |
279,693
| – | – | 0.01% | 112 |
|
|
2024
Q3 | $5.75M | Hold |
279,693
| – | – | 0.02% | 91 |
|
|
2024
Q2 | $6.26M | Hold |
279,693
| – | – | 0.03% | 79 |
|
|
2024
Q1 | $7.69M | Hold |
279,693
| – | – | 0.04% | 67 |
|
|
2023
Q4 | $8.53M | Hold |
279,693
| – | – | 0.05% | 53 |
|
|
2023
Q3 | $8.84M | Buy |
279,693
+75,417
| +37% | +$2.93M | 0.05% | 54 |
|
|
2023
Q2 | $8.33M | Hold |
204,276
| – | – | 0.05% | 53 |
|
|
2023
Q1 | $7.61M | Hold |
204,276
| – | – | 0.05% | 53 |
|
|
2022
Q4 | $7.13M | Hold |
204,276
| – | – | 0.04% | 57 |
|
|
2022
Q3 | $11.4M | Hold |
204,276
| – | – | 0.07% | 55 |
|
|
2022
Q2 | $10.6M | Hold |
204,276
| – | – | 0.06% | 68 |
|
|
2022
Q1 | $14.8M | Hold |
204,276
| – | – | 0.06% | 74 |
|
|
2021
Q4 | $24.2M | Sell |
204,276
-397,563
| -66% | -$49.8M | 0.09% | 67 |
|
|
2021
Q3 | $80.7M | Sell |
601,839
-188,688
| -24% | -$28.6M | 0.28% | 47 |
|
|
2021
Q2 | $128M | Hold |
790,527
| – | – | 0.43% | 36 |
|
|
2021
Q1 | $63.4M | Hold |
790,527
| – | – | 0.25% | 43 |
|
|
2020
Q4 | $43M | Hold |
790,527
| – | – | 0.18% | 49 |
|
|
2020
Q3 | $15.7M | Hold |
790,527
| – | – | 0.08% | 54 |
|
|
2020
Q2 | $16.6M | Hold |
790,527
| – | – | 0.1% | 43 |
|
|
2020
Q1 | $9.67M | Hold |
790,527
| – | – | 0.07% | 45 |
|
|
2019
Q4 | $11.6M | Hold |
790,527
| – | – | 0.08% | 48 |
|
|
2019
Q3 | $10.6M | Hold |
790,527
| – | – | 0.08% | 48 |
|
|
2019
Q2 | $12.9M | Hold |
790,527
| – | – | 0.09% | 45 |
|
|
2019
Q1 | $13.5M | Hold |
790,527
| – | – | 0.09% | 41 |
|
|
2018
Q4 | $10.8M | Hold |
790,527
| – | – | 0.07% | 51 |
|
|
2018
Q3 | $22.6M | Hold |
790,527
| – | – | 0.13% | 45 |
|
|
2018
Q2 | $21.6M | Hold |
790,527
| – | – | 0.11% | 48 |
|
|
2018
Q1 | $16.7M | Hold |
790,527
| – | – | 0.09% | 52 |
|
|
2017
Q4 | $15.2M | Hold |
790,527
| – | – | 0.09% | 52 |
|
|
2017
Q3 | $19.6M | Hold |
790,527
| – | – | 0.11% | 47 |
|
|
2017
Q2 | $12.6M | Hold |
790,527
| – | – | 0.08% | 46 |
|
|
2017
Q1 | $11.1M | Hold |
790,527
| – | – | 0.08% | 34 |
|
|
2016
Q4 | $10.4M | Hold |
790,527
| – | – | 0.08% | 35 |
|
|
2016
Q3 | $13.5M | Hold |
790,527
| – | – | 0.11% | 28 |
|
|
2016
Q2 | $16.9M | Buy |
+790,527
| New | +$21M | 0.13% | 25 |
|
Other funds holding NTLA
AIM
RP
NAMA
Temasek Holdings's NTLA Position: Q1 2025 in Review
Temasek Holdings sold out of Intellia Therapeutics (NTLA) in Q1 2025, closing a stake of 279,693 shares — an estimated $3.26M sold.
Temasek Holdings first reported a position in NTLA in Q2 2016 and held it in 35 quarters. The position peaked at $128M in Q2 2021. 294 funds tracked by Wall St. Rank hold NTLA as of Q1 2025.
- Temasek Holdings reported no remaining Intellia Therapeutics position as of Q1 2025 after selling out during the quarter.
- Temasek Holdings sold 279,693 Intellia Therapeutics shares in Q1 2025, an estimated $3.26M.
- Temasek Holdings first reported a position in Intellia Therapeutics in Q2 2016 and held it in 35 quarters.
- Temasek Holdings's Intellia Therapeutics position peaked at $128M in Q2 2021.
- 294 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2025.
Based on Temasek Holdings's 13F filing for Q1 2025, filed 16 May 2025.